Return to content in this issue
JAK Inhibition as a Therapeutic Strategy for IgG4-RD
Khan S1, Gordins P1, Durairaj S2
1Department of Immunology & Allergy, Castle Hill Hospital, Cottingham, UK
2Department of Haemato-Oncology, Castle Hill Hospital, Cottingham, UK
J Investig Allergol Clin Immunol 2021; Vol 31(3)
: 280-281
doi: 10.18176/jiaci.0654
Key words: IgG4-related disease, IgG4-RD, Fibrosis, Cytokines, JAK inhibition